ARN-6039

· Arrien Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ARN-6039, covering 2017-08-03 to 2017-08-03. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of ARN-6039 [Phase 1]